enVVeno Medical Corp Increase (Decrease) in Accounts Payable and Accrued Liabilities
enVVeno Medical Corp (NVNO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$247.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-30
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$262.00K, a 119.45% decline year-over-year.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $15.00K.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$382.00K.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$524.00K, a 199.24% decline year-over-year.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $1.00K, a 99.86% decline from fiscal 2024.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $698.00K.
- enVVeno Medical Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$183.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$247.00K 10-Q · filed 2026-07-30 | -$629.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.15M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $15.00K 10-Q · filed 2026-05-06 | -$367.00K derived: sum of 2 quarters · filed 2026-05-06 | -$891.00K derived: sum of 3 quarters · filed 2026-05-06 | $456.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$906.00K derived: sum of 2 quarters · filed 2026-03-26 | $441.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | -$524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $823.00K derived: sum of 2 quarters · filed 2026-07-30 | $383.00K 10-Q · filed 2025-10-30 | $242.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $907.00K 10-Q · filed 2026-07-30 | $766.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.29M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$440.00K 10-Q · filed 2026-05-06 | -$581.00K derived: sum of 2 quarters · filed 2026-05-06 | -$53.00K derived: sum of 3 quarters · filed 2026-05-06 | $148.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $387.00K derived: sum of 2 quarters · filed 2026-03-26 | $588.00K derived: sum of 3 quarters · filed 2026-03-26 | $698.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $729.00K derived: sum of 2 quarters · filed 2025-10-30 | $839.00K 10-Q · filed 2025-10-30 | $172.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $311.00K 10-Q · filed 2025-07-31 | -$356.00K derived: sum of 3 quarters · filed 2025-07-31 | |
| 2024-03-31 | $110.00K 10-Q · filed 2025-04-30 | -$557.00K derived: sum of 2 quarters · filed 2025-04-30 | ||
| 2023-12-31 | -$667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$183.00K 10-K · filed 2025-02-28 | ||
| 2023-09-30 | $484.00K 10-Q · filed 2024-10-31 | |||
| 2023-03-31 | -$369.00K 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | -$293.00K 10-Q · filed 2023-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |